Shanghai Labway Clinical Laboratory Co., Ltd

¥9.87As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301060Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (10.11%)
Div yield 1.82%
ROE 3.10%
Diagnostics & Research
Beta (5Y) 0.89
PE TTM 93.63
TSR TTM 4.30%
Mkt cap ¥3.933B
ROIC 4.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
29.35%
(12.65%)
Hold 11|10|7|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.23
0.23
0.23
0.25
11.77%
9.11%
15.80%
9.55%
Revenue¥M
227.7
231.0
241.9
251.6
1.23%
(2.15%)
1.70%
7.79%
Peers (US$589.6M)
Cap (US$)
PE
540.0M
53.92x
586.0M
36.73x
Capital
TTM
5Y
10Y
Leveragex
0.961
(0.061)
(0.064)
EBIT/Intx
12.05
0.082
0.107
Own earn%
(11.01)
69.51
57.03
Sh yield%
8.45
36.80
33.71
Owners
Insiders/Inst%
7.02
66.63
Short interest%
5.06
SBC / revenue%
5.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
17–22
$1 testx
0.1
Incr. ROIC%
−9